Biotech News
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
investors.adaptivebiotech.com2026-05-06 14:55 EST
SEATTLE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced Dr.